Show simple item record

dc.creatorTerruzzi, Ileana
dc.creatorSenesi, Pamela
dc.date.accessioned2020-09-07T14:47:25Z
dc.date.available2020-09-07T14:47:25Z
dc.date.created2020
dc.identifier.issn0899-9007spa
dc.identifier.otherhttps://doi.org/10.1016/j.nut.2020.110996spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/12809
dc.description.abstractIn few months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become the main health worldwide problem. Epidemiological studies revealed that population has different vulnerability to SARS-CoV-2: severe outcome of COVID-19, with an increased risk of death, is observed in patients with metabolic syndrome, diabetic and heart conditions (frail population). Excessive pro-inflammatory cytokine storm could be the main cause of enlarged vulnerability in frail population. In subjects with diabetes and/or heart disease, a low inflammatory state is often associated with gut dysbiosis. The increase of microbial metabolites (i.e. TMAO and LPS), generating an inflammatory microenvironment is probably associated with an improved risk of severe illness from COVID-19. Nutritional interventions aimed at restoring gut microbial balance could represent preventive strategies to protect frail population from COVID-19. This narrative review presents the possible molecular mechanisms by which intestinal dysbiosis, enhancing inflammatory state, could promote SARS-CoV-2 spreading infection. Some nutritional strategies to counteract inflammation state in frail patients are also analysed.spa
dc.format.extent23 páginasspa
dc.format.mimetypeimage/jepgspa
dc.language.isoengspa
dc.publisherNutritionspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectSARS-CoV-2spa
dc.subjectCOVID-19spa
dc.subjectMetabolic syndromespa
dc.subjectCardiovascular diseasesspa
dc.subjectGut dysbiosisspa
dc.subjectNutraceuticalsspa
dc.titleDoes intestinal dysbiosis contribute to an aberrant inflammatory response to SARS-CoV-2 in frail patients?spa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/embargoedAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAcceso restringidospa
dc.identifier.doihttps://doi.org/10.1016/j.nut.2020.110996spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record